Group 1 - Madison Square Garden (MSGS) reported revenue of $203.96 million for the quarter ended June 2025, a decrease of 10.3% year-over-year, with an EPS of -$0.07 compared to $1.06 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $165.69 million by 23.1%, and the EPS surprised by 83.33% against the consensus estimate of -$0.42 [1] - The stock has returned -4.3% over the past month, underperforming the Zacks S&P 500 composite's +3.1% change, and currently holds a Zacks Rank 5 (Strong Sell) [3] Group 2 - Total revenues from event-related contracts were $140.32 million, surpassing the average estimate of $88.37 million, but reflecting a year-over-year decline of 7.8% [4] - League distributions and other revenues totaled $3.99 million, below the average estimate of $5.08 million, marking a significant year-over-year decrease of 66.8% [4] - Sponsorship, signage, and suite licenses generated $31.88 million, slightly above the estimated $29.22 million, but down 8.2% compared to the previous year [4] - Media rights revenues were reported at $27.77 million, slightly below the estimated $28.38 million, with a year-over-year decline of 2.3% [4]

Core Insights - Plymouth Industrial reported revenue of $47.2 million for the quarter ended June 2025, reflecting a decrease of 3.1% year-over-year, but a surprise of +1.07% over the Zacks Consensus Estimate of $46.71 million [1] - The company's EPS for the quarter was $0.46, significantly higher than $0.03 in the same quarter last year, and exceeded the consensus estimate of $0.43 by +6.98% [1] Revenue Breakdown - Management fee revenue and other income amounted to $0.15 million, surpassing the average estimate of $0.13 million by two analysts, representing a year-over-year increase of +294.6% [4] - Rental revenue was reported at $47.06 million, slightly above the estimated $46.08 million by two analysts, but down 3.3% compared to the previous year [4] Stock Performance - Over the past month, shares of Plymouth Industrial have declined by -9.6%, contrasting with a +0.5% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), suggesting potential for outperformance against the broader market in the near term [3]

Core Insights - Guardant Health reported a revenue of $232.09 million for the quarter ended June 2025, reflecting a 31% increase year-over-year and surpassing the Zacks Consensus Estimate of $211.43 million by 9.77% [1] - The company’s EPS was -$0.44, an improvement from -$0.48 in the same quarter last year, with an EPS surprise of 15.38% against the consensus estimate of -$0.52 [1] Revenue Breakdown - Oncology revenue reached $158.69 million, exceeding the three-analyst average estimate of $153.38 million [4] - Licensing and other revenue was $2.57 million, surpassing the average estimate of $1.81 million from three analysts [4] - Screening revenue amounted to $14.81 million, significantly higher than the three-analyst average estimate of $8.31 million [4] - Biopharma and data revenue totaled $56.02 million, exceeding the average estimate of $48.06 million from three analysts [4] Stock Performance - Over the past month, shares of Guardant Health have declined by 14.6%, while the Zacks S&P 500 composite increased by 3.4% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Core Insights - Fortune Brands Innovations (FBIN) reported a revenue of $1.03 billion for Q1 2025, reflecting a year-over-year decline of 6.9% and an EPS of $0.66, down from $0.83 a year ago, with a revenue surprise of -3.39% compared to the Zacks Consensus Estimate of $1.07 billion [1] Financial Performance - The company’s net sales in the Outdoors segment were $304.70 million, slightly below the average estimate of $309.50 million, marking a year-over-year decline of 3.3% [4] - In the Security segment, net sales reached $163 million, exceeding the average estimate of $155.76 million, but still reflecting a year-over-year decrease of 3.7% [4] - Water segment net sales were reported at $565.40 million, significantly below the average estimate of $608.31 million, with a year-over-year decline of 9.6% [4] Operating Income - Non-GAAP operating income for the Water segment was $113.20 million, compared to the average estimate of $127.41 million [4] - Non-GAAP operating income for the Outdoors segment was $31.70 million, slightly below the average estimate of $33.18 million [4] - The Security segment reported a Non-GAAP operating income of $23.20 million, surpassing the average estimate of $15.80 million [4] - Total corporate expenses were reported at -$32.30 million, better than the average estimate of -$39.65 million [4] Stock Performance - Shares of Fortune Brands Innovations have returned +6.6% over the past month, underperforming the Zacks S&P 500 composite's +11.5% change, and the stock currently holds a Zacks Rank 4 (Sell) [3]